Does out-of-office home blood pressure monitoring over seven days provide equivalent or superior diagnostic accuracy and clinical outcomes compared to immediate first-line pharmacotherapy for stage 1 hypertension without end-organ damage?

No direct evidence for out-of-office home blood pressure monitoring over seven days compared to immediate pharmacotherapy in stage 1 hypertension without end-organ damage was identified. HBPM shows promise in improving diagnostic accuracy and reducing unnecessary treatments, but its impact on clinical outcomes compared to pharmacotherapy remains to be clarified.